Vasculitis and Giant Cell Arteritis News

Distinct clinical features, such as more renal involvement, were observed in patients with late onset immunoglobulin A vasculitis compared to patients with early onset vasculitis, according to recently published data.

The anti-pneumococcal polysaccharide vaccine appears to be preserved for at least 10 years among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and inflammatory bowel disease-associated spondyloarthritis, although efficacy may be diminished by methotrexate use, according to researchers from the Department of Rheumatology in the Tel Aviv Medical Center, Sackler School of Medicine at Tel Aviv University, Tel Aviv, Israel.

The American Autoimmune Related Diseases Association has released a report available to the public that addresses topics in autoimmune diseases, research and patient information following a one-day autoimmune summit in Washington, D.C., that involved about 20 researchers.

It may be possible to predict the relapse of giant cell arteritis after tapering glucocorticoids via the presence of higher levels of markers of systemic inflammation at the time of diagnosis, according to recently presented data.

In a study of German patients with rheumatic diseases treated with biologics, the incidence of reactivation of the hepatitis B virus was uncommon, according to recently presented data.

Royal Philips announced the release of Lumify, a subscription-based smart device ultrasound solution for purchase by licensed U.S. health care providers and organizations.

Welcome to the Premier Issue of Healio Rheumatology, a print publication based on the most important news as measured by the online preferences of your colleagues. In this issue, you will find the most-read content from readers of Healio.com/Rheumatology, our online news site for rheumatology. We call this unique approach to issue content selection “Peer-Tested Content” and we believe the approach will provide you the best and most valuable content in your area of expertise.

The Richard J. Fasenmyer Foundation has awarded $18.5 million in new grants to Cleveland Clinic and Case Western Reserve University School of Medicine in support of collaborative research, physician recruitment and junior faculty research, and to sustain the Richard J. Fasenmyer Center for Clinical Immunology at Cleveland Clinic.

Genentech announced completed enrollment of a phase 3 trial on Actemra for the treatment of giant cell arteritis, according to a company press release.